AlphaGene, Wayne State Partner to Study Brain Tumors | GenomeWeb

NEW YORK, Sept 11 – AlphaGene of Woburn, Mass., said Tuesday it has signed an agreement with Wayne State University to study malignant brain tumor cell types using gene expression technology.

Under the terms of the deal, AlphaGene will contribute its expertise in functional genomics, while Wayne State University will provide its research capabilities. Financial terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.